These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30382303)

  • 1. Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease.
    De Carli F; Nobili F; Pagani M; Bauckneht M; Massa F; Grazzini M; Jonsson C; Peira E; Morbelli S; Arnaldi D;
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):334-347. PubMed ID: 30382303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison.
    Caroli A; Prestia A; Chen K; Ayutyanont N; Landau SM; Madison CM; Haense C; Herholz K; Nobili F; Reiman EM; Jagust WJ; Frisoni GB;
    J Nucl Med; 2012 Apr; 53(4):592-600. PubMed ID: 22343502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study.
    Pagani M; De Carli F; Morbelli S; Öberg J; Chincarini A; Frisoni GB; Galluzzi S; Perneczky R; Drzezga A; van Berckel BN; Ossenkoppele R; Didic M; Guedj E; Brugnolo A; Picco A; Arnaldi D; Ferrara M; Buschiazzo A; Sambuceti G; Nobili F
    Neuroimage Clin; 2015; 7():34-42. PubMed ID: 25610765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
    Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
    J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selecting the most relevant brain regions to discriminate Alzheimer's disease patients from healthy controls using multiple kernel learning: A comparison across functional and structural imaging modalities and atlases.
    Rondina JM; Ferreira LK; de Souza Duran FL; Kubo R; Ono CR; Leite CC; Smid J; Nitrini R; Buchpiguel CA; Busatto GF
    Neuroimage Clin; 2018; 17():628-641. PubMed ID: 29234599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).
    Bauckneht M; Chincarini A; Piva R; Arnaldi D; Girtler N; Massa F; Pardini M; Grazzini M; Efeturk H; Pagani M; Sambuceti G; Nobili F; Morbelli S
    Alzheimers Res Ther; 2018 Apr; 10(1):35. PubMed ID: 29615111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease.
    Brugnolo A; De Carli F; Pagani M; Morbelli S; Jonsson C; Chincarini A; Frisoni GB; Galluzzi S; Perneczky R; Drzezga A; van Berckel BNM; Ossenkoppele R; Didic M; Guedj E; Arnaldi D; Massa F; Grazzini M; Pardini M; Mecocci P; Dottorini ME; Bauckneht M; Sambuceti G; Nobili F
    J Alzheimers Dis; 2019; 68(1):383-394. PubMed ID: 30776000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
    Morbelli S; Bauckneht M; Arnaldi D; Picco A; Pardini M; Brugnolo A; Buschiazzo A; Pagani M; Girtler N; Nieri A; Chincarini A; De Carli F; Sambuceti G; Nobili F
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2073-2083. PubMed ID: 28785843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Neurosci Methods; 2015 Dec; 256():168-83. PubMed ID: 26318777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early identification of MCI converting to AD: a FDG PET study.
    Pagani M; Nobili F; Morbelli S; Arnaldi D; Giuliani A; Öberg J; Girtler N; Brugnolo A; Picco A; Bauckneht M; Piva R; Chincarini A; Sambuceti G; Jonsson C; De Carli F
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2042-2052. PubMed ID: 28664464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.
    Ben Bouallègue F; Mariano-Goulart D; Payoux P;
    J Alzheimers Dis; 2018; 62(1):399-408. PubMed ID: 29439345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controls-based denoising, a new approach for medical image analysis, improves prediction of conversion to Alzheimer's disease with FDG-PET.
    Blum D; Liepelt-Scarfone I; Berg D; Gasser T; la Fougère C; Reimold M;
    Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2370-2379. PubMed ID: 31338550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and comparative evaluation of different activity detection methods in brain FDG-PET.
    Buchholz HG; Wenzel F; Gartenschläger M; Thiele F; Young S; Reuss S; Schreckenberger M
    Biomed Eng Online; 2015 Aug; 14():79. PubMed ID: 26281849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.
    Habeck C; Risacher S; Lee GJ; Glymour MM; Mormino E; Mukherjee S; Kim S; Nho K; DeCarli C; Saykin AJ; Crane PK;
    Brain Imaging Behav; 2012 Dec; 6(4):568-83. PubMed ID: 23179062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.
    Cerami C; Della Rosa PA; Magnani G; Santangelo R; Marcone A; Cappa SF; Perani D
    Neuroimage Clin; 2015; 7():187-94. PubMed ID: 25610780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging.
    Choi H; Jin KH;
    Behav Brain Res; 2018 May; 344():103-109. PubMed ID: 29454006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-Modality Sparse Representation for Alzheimer's Disease Classification.
    Kwak K; Yun HJ; Park G; Lee JM;
    J Alzheimers Dis; 2018; 65(3):807-817. PubMed ID: 29562503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiscale deep neural network based analysis of FDG-PET images for the early diagnosis of Alzheimer's disease.
    Lu D; Popuri K; Ding GW; Balachandar R; Beg MF;
    Med Image Anal; 2018 May; 46():26-34. PubMed ID: 29502031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning identified an Alzheimer's disease-related FDG-PET pattern which is also expressed in Lewy body dementia and Parkinson's disease dementia.
    Katako A; Shelton P; Goertzen AL; Levin D; Bybel B; Aljuaid M; Yoon HJ; Kang DY; Kim SM; Lee CS; Ko JH
    Sci Rep; 2018 Sep; 8(1):13236. PubMed ID: 30185806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
    Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A
    J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.